Investigators showed that expression of Vav1-Myo1f, a recurrent peripheral T cell lymphoma-associated VAV1 fusion, induces oncogenic transformation of CD4+ T cells.
[Cell Reports]
Oncogenic Vav1-Myo1f Induces Therapeutically Targetable Macrophage-Rich Tumor Microenvironment in Peripheral T Cell Lymphoma
